drugset / Trial / NCT06709807

Clinical Study to Evaluate the Food Effect of CKD-378 in Healthy Volunteers

NCT06709807

Phase 1 Completed 31 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

This study is a randomized, open-label, single dose, crossover study to evaluate the food effect of CKD-378 in healthy volunteers

Timeline

Start
2024-11-08
Primary completion
2024-12-07
Completion
2024-12-19

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-378 Unknown 25 mg Oral
Subject CKD-378 Unknown 1000 mg Oral